medical device
4 stories filed under medical device on Beyond Market Intelligence. The newest of them: “A new implant brings vision restoration closer for Stargardt patients”, “Voice loss sparked this founder's mission to restore emotion in speech”, and “Boston Scientific cyberattack disrupts global operations, device impact unclear”. Max Hodak took the stage at TechCrunch Disrupt to share how his company's work with PRIMA brings vision restoration closer for Stargardt patients. Losing your voice means losing a piece of who you are. Acme AI is the next-generation, AI-powered spreadsheet platform built to replace Excel and redefine how analysts, data scientists, and enterprise teams work… The list below is every medical device story on Beyond Market Intelligence, newest first.
A new implant brings vision restoration closer for Stargardt patients
Max Hodak took the stage at TechCrunch Disrupt to share how his company's work with PRIMA brings vision restoration closer for Stargardt patients. This isn't just incremental progress; it's a deliberate step toward a novel brain-computer interface. For anyone tracking the future of data and biology, this pairs naturally with coverage of Longshot's ambitious space data centers, both stories explore frontiers that feel distant yet suddenly tangible.
Voice loss sparked this founder's mission to restore emotion in speech
Losing your voice means losing a piece of who you are. That's the spark behind Uhura Bionics, part of the Startup Battlefield 200 at TechCrunch Disrupt. The founder watched robotic, flat speech fail to carry real feeling, and set out to change that. This isn't just about clearer sound; it's about restoring the emotion that makes us human. It's a mission worth hearing. For more on founders turning personal pain into progress, explore how travel leads Instinct's daily growth with 10% momentum.
Boston Scientific cyberattack disrupts global operations, device impact unclear
Boston Scientific is facing a serious test of trust after confirming a cyberattack has thrown its operations into global disruption. The medical device maker hasn't yet said whether patient data was taken or if any devices are compromised, leaving a lot of uncertainty in the air. That silence is concerning for a company people rely on for critical care. When infrastructure this essential gets hit, transparency matters as much as the fix.
A vision-restoring implant earns EU approval, opening new data frontiers.
Science Corp.'s vision-restoring chip just cleared EU approval, and CEO Max Hodak's take cuts straight to the point: the field needs a company pulling in real revenue, not just promising headlines. That pragmatism is exactly what this space has lacked. It's one thing to build transformative tech; it's another to make it sustainable enough to matter. For anyone watching how AI-native tools reshape industries, this is a signal worth exploring.